SJIF(2020): 5.702

International Journal of Advanced Research and Publications

High Quality Publications & World Wide Indexing!

Ayurvedic Management Of Psoriasiform Illness (Kaphaja Uttana Vatarakta): A Case Study.

Volume 5 - Issue 10, October 2022 Edition
[Download Full Paper]

Dr. Mansi Grewal, Dr. Yogesh Kumar Pandey
Ayurved, Dyslipidemia, PASI, Psoriasiform illness, Vatarakta,
Psoriasis is a skin disease characterized by well-demarcated, erythematous, papules to rounded plaques with silvery micaceous scale. Psoriasis is often associated with dyslipidemia and obesity is a risk factor for psoriasis. Pro-inflammatory cytokines TNF, IL-1, IL-6 are common between psoriasis, dyslipidemia, and obesity. Although psoriasis has been long viewed and treated as Kushtha, it may be seen and managed along the lines of Uttana Vatarakta with variable Dosha presentations. In this article, the case of a patient with psoriasiform illness and dyslipidemia is described. The patient was prescribed ayurvedic treatment for three months duration. His PASI score and lipid profile were assessed during the course of the intervention. The patient showed a marked reduction in all components of PASI score and improvement in lipid profile. A combination of Triphla guggulu, Navakarshika Kashaya, Tab. Imupsora, Jatyadi oil, and ointment Imupsora is found effective in reducing PASI score in psoriasiform lesions, relieving the discomforting symptoms, and combating psoriatic comorbidity of dyslipidemia. This ayurvedic regime successfully weaned the patient from antihistamines and was well tolerated, without any reported side effects. The response of our ayurvedic treatment was found satisfactory by the patient and it was met with discontinuation of other contemporary drugs such as antihistamines. The itching was the most notorious symptom which was dealt with over the course of treatment.
[1] Kang S, Amagai M, Bruckner A, Elk A, Margolis D, McMichael A et al. Fitzpatrick's dermatology. Volume 1.9th ed. Mc Graw-Hill Education; 2019.p.458-459

[2] Jensen P, Skov L. Psoriasis and obesity. Dermatology. 2016;232(6):633-9.

[3] Jamil A, Ahsan U, Malik LM, Azfar NA, Jahangir M. Frequency of dyslipidemia in patients with psoriasis. Journal of Pakistan Association of Dermatologists. 2014;24(4):307-11.

[4] Salihbegovic EM, Hadzigrahic N, Suljagic E, Kurtalic N, Hadzic J, Zejcirovic A, Bijedic M, Handanagic A. Psoriasis and dyslipidemia. Materia Socio-Medica. 2015 Feb;27(1):15.

[5] Charaka Samhita, Chikitsa Sthana Vatashonitachikitsa 29/20, Available from: http://niimh.nic.in/ebooks/ echarak. [Last accessed on 2022 July 19].

[6] Charaka Samhita, Chikitsa Sthana Vatashonitachikitsa 29/156, Available from: http://niimh.nic.in/ebooks/ echarak. [Last accessed on 2022 July 19].

[7] Acharya Sharangdhar. Madhyamkhanda, Vatak Kalpana 7/82-83. In(eds.) Tripathi, B. Sharangdhar Samhita. Chaukhamba Surbharti Prakashan. Varanasi. 2013.p.137

[8] Chakrapanidutta, S. Vatarakta Chikitsa. In: Tripathi, J.P (ed.) Chakradutta. Varanasi: Chaukhamba Sanskrit Series Office; p. 218.

[9] Acharya Sharangdhar. Madhyamkhanda, Ghritataila Kalpana 9/168-171. In(eds.) Tripathi, B. Sharangdhar Samhita. Chaukhamba Surbharti Prakashan. Varanasi. 2013.p.159